Fig. 3From: Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical studyROC curves. RPA recursive partitioning analysis, RECIST Response Evaluation Criteria in Solid Tumours 1.1, PERCIST Positron Emission Tomography Response Criteria in Solid Tumours 1.0Back to article page